Terminally ill patients are seeking access to psilocybin under Right to Try, a federal law and an array of state laws meant to grant people facing death access to experimental drugs outside of a clinical trial, but the DEA says Right to Try doesn’t permit an exemption to the Controlled Substances Act, reports Bloomberg News.
Allowing access to a Schedule I drug under Right to Try could open a can of worms for the DEA, who say that the law does permit access to Schedule I drugs for researchers and that petitioners could apply for permission to do said research. Right to Try was intended to ensure the Food and Drug Administration allows the terminally ill to try yet-to-be-approved drugs. Advocates say that the caveat should apply to the DEA too.